Literature DB >> 6188693

Effects of captopril and enalapril on regional vascular resistance and reactivity in spontaneously hypertensive rats.

C Richer, M P Doussau, J F Giudicelli.   

Abstract

The present study compares the effects of short-term treatments with captopril and enalapril, administered in equipotent antihypertensive doses, on the regional vascular resistances and on the regional vascular responsiveness to vasopressor agents of adult spontaneously hypertensive rats (SHRs). Three groups of animals were treated by gavage with captopril (100 mg/kg), enalapril (25 mg/kg), or distilled water for 8 days. Arterial blood pressure (BP), heart rate (HR), plasma renin concentration (PRC), and plasma converting-enzyme activity (CEA) were measured. Cardiac index (CI), total peripheral resistance (PR), and organ flow distribution were determined using microspheres. Renal and mesenteric vascular responsiveness to vasopressor agents was evaluated by continuous measurement of renal and mesenteric blood flows with miniaturized pulsed Doppler flow probes. Data showed that in the anesthetized SHR the two drugs induced similar reductions in BP, PR, and HR, without affecting CI. They simultaneously produced a strong converting-enzyme inhibition as evidenced by the suppression of angiotensin I effects accompanied by a potentiation of angiotensin II responses, a reduction in CEA, and an increase in PRC. Organ flows were similarly and homogeneously increased, especially in the kidneys, in both treated groups. Norepinephrine (NE) vasoconstrictor responses were abolished in the mesenteric vascular bed by both drugs, but in the renal, NE responses although completely abolished by captopril were only partially reduced by enalapril. It thus appears that diminished vascular responsiveness to NE, especially in the case of captopril, is probably involved along with converting-enzyme inhibition in the antihypertensive action of converting enzyme inhibitors (CEI), the mechanism of the difference between captopril and enalapril remaining still speculative.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6188693     DOI: 10.1161/01.hyp.5.3.312

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  7 in total

1.  The subtype 2 of angiotensin II receptors and pressure-natriuresis in adult rat kidneys.

Authors:  K L Liu; M Lo; E Grouzmann; M Mutter; J Sassard
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

2.  Changes in haemodynamics and body fluid volume due to enalapril in patients with essential hypertension on chronic diuretic therapy.

Authors:  B A van Schaik; G G Geyskes; P Boer; E J Dorhout Mees
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

Review 3.  Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Authors:  P A Todd; R C Heel
Journal:  Drugs       Date:  1986-03       Impact factor: 9.546

4.  Differential systemic and regional hemodynamic profiles of four angiotensin-I converting-enzyme inhibitors in the rat.

Authors:  C Richer; M P Doussau; J F Giudicelli
Journal:  Cardiovasc Drugs Ther       Date:  1989-12       Impact factor: 3.727

5.  The effect of enalapril on baroreceptor mediated reflex function in normotensive subjects.

Authors:  J F Giudicelli; A Berdeaux; A Edouard; C Richer; D Jacolot
Journal:  Br J Clin Pharmacol       Date:  1985-09       Impact factor: 4.335

6.  Effects of chronic heart failure on the responsiveness to angiotensin I and to angiotensin converting enzyme inhibition with cilazapril in rats.

Authors:  J P Clozel
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

7.  The effect of acute and chronic captopril therapy on baroreflex function in man.

Authors:  G B Kondowe; A H Deering; J G Riddell; G D Johnston; D W Harron
Journal:  Br J Clin Pharmacol       Date:  1988-03       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.